Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Immunocore’s new CFO carries a torch for dealmaking. Formerly the head of transactions and M&A for Eli Lilly’s corporate business development, Travis Coy is bringing some of that Big Pharma energy to the mid-sized drugmaker.